T cell response to Hu-D peptides in patients with anti-Hu syndrome

By Rousseau A.   Benyahia B.   Dalmau J.   Connan F.   Guillet J.   Delattre J.   Choppin J.  

Journal of Neuro-Oncology, Vol. 71, Iss. 3, 2005-02 ,pp. : 231-236

Springer Publishing Company

Access to resources Recommend Favorite

U.V. Enhanced Reactivation of U.V.- and γ-irradiated Adenovirus in Cockayne Syndrome and Xeroderma Pigmentosum Fibroblasts

By Jeeves W. Patrick   Rainbow Andrew J.  

International Journal of Radiation Biology, Vol. 43, Iss. 6, 1983-06 ,pp. : 625-647

Informa Healthcare

Access to resources Recommend Favorite

Vitamin D deficiency and supplementation in patients with aggressive B‐cell lymphomas treated with immunochemotherapy

By  

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 270-281

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma

By Lee Jeeyun   Im Young-Hyuck   Cho Eun   Hong Yong   Lee Hyo   Kim Hyo   Kim Mi-Jin   Kim Kwhanmien   Kang Won   Park Keunchil   Shim Young  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 77-84

Springer Publishing Company

Access to resources Recommend Favorite

The Bowman-Birk protease inhibitor enhances clonogenic cell survival of ionizing radiation-treated nucleotide excision repair-competent cells but not of xeroderma pigmentosum cells

By Dittmann K. H.   Dikomey E.   Mayer C.   Rodemann H. P.  

International Journal of Radiation Biology, Vol. 76, Iss. 2, 2000-02 ,pp. : 223-229

Informa Healthcare

Access to resources Recommend Favorite